Analysis of Over 25 Lakh+ Health Checks Reveals a Shift Towards Preventive Healthcare in India: Redcliffe Labs

IMT News Desk
IMT News Desk
· 2 min read
Redcliffe Labs data shows preventive health checkups are rising, led by Gen Z, Tier-2 cities, and more proactive diagnostic habits.

An analysis of more than 25 lakh health checks conducted by Redcliffe Labs across FY25 and FY26 shows a clear shift in how Indians are approaching diagnostics, with preventive healthcare steadily gaining momentum alongside traditional reactive testing. While symptom-led testing still accounts for a large share of diagnostic activity, the data suggest that more consumers are now opting for routine checkups, early detection, and wellness monitoring as part of long-term health management.

The study found that nearly 60% of all diagnostic bookings at Redcliffe were preventive, underscoring the growing importance of proactive health management across age groups. This trend is especially strong among younger consumers, with nearly 2 in 3 Gen Z bookings driven by wellness and preventive needs. Millennials, meanwhile, showed a more balanced approach, with only about 1 in 2 bookings linked to preventive or wellness testing, indicating a gradual transition between reactive and proactive care patterns.

The analysis also highlighted notable regional differences in health-seeking behaviour. Tier-2 cities recorded a higher share of preventive health checkups than Tier-1 markets, suggesting that awareness around routine screening and early risk detection is expanding beyond metro centres. This finding challenges the long-held assumption that preventive healthcare adoption is strongest only in large urban markets and points to a broader national shift in health consciousness.

Gender-wise, the data revealed distinct patterns in diagnostic behaviour. Men allocated nearly 65% of their diagnostic activity to preventive health checkups, while women were more inclined towards reactive testing. The findings suggest there is significant room to strengthen awareness and accessibility around preventive screening among women through targeted outreach and routine health initiatives.

Taken together, the analysis indicates that preventive healthcare is no longer limited to a niche segment. It is increasingly becoming a mainstream habit, driven by younger consumers, expanding awareness, and rising adoption in emerging cities. As this shift continues, diagnostics are evolving from a disease-detection tool into a more central part of proactive health and wellness management.

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk